Trinseo (NYSE: TSE), the global materials solution provider and manufacturer of plastics, latex binders and synthetic rubber, announced today that its Consumer Essential Markets (CEM) business unit will now support medical device and pharmaceutical manufacturers of Drug Delivery Devices with specialty engineered polymer solutions.
Typical drug delivery devices, also known as combination devices that can use Trinseo materials include auto injectors, insulin pens, asthma inhalers, prefilled syringes and wearable devices. The Company’s specialty compounded solutions are ideal for a wide range of applications – acrylonitrile butadiene styrene (ABS) for housings, polycarbonate (PC) for windows and needle shield caps, and polystyrene (PS) for secondary packaging.
Trinseo materials are offered under the brands CALIBRE™ Polycarbonate Resins, CALIBRE™ MEGARAD™ Polycarbonate Resins, EMERGE™ Advanced Resins, STYRON™ Polystyrene Resins and MAGNUM™ ABS Resins. They provide advantages which are critical to the market such as:
Trinseo materials have been developed to meet the needs of manufacturers and molders - and they can be customized to meet exacting specifications. Trinseo medical grades have been biocompatibility tested and certain products are listed on a U.S. FDA Master Access File or Drug Master File.
The Company’s focus on drug delivery devices expands its support in the Medical Devices space which has included Single- and Multiple-Use Devices and Equipment Housings. As healthcare professionals embrace self-administered care they need devices that not only are effective therapeutically but also offer their patients functionality, convenience, haptics and aesthetics. Polymers are a big part of the challenge and Trinseo, with a foundation in medical polymers, intends to offer the solution.
Trinseo (NYSE:TSE) is a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber with a focus on delivering innovative, sustainable, and value-creating products that are intrinsic to our daily lives. Trinseo is dedicated to making a positive impact on society by partnering with like-minded stakeholders, and supporting the sustainability goals of our customers in a wide range of end-markets including automotive, consumer electronics, appliances, medical devices, packaging, footwear, carpet, paper and board, building and construction, and tires. Trinseo had approximately $3.8 billion in net sales with 2,700 employees globally in 2019. For more information, please visit: www.trinseo.com.
This press release may contain “forward-looking statements” including, without limitation, statements concerning plans, objectives, goals, projections, expectations, strategies, future events or performance, and underlying assumptions and other statements, which are not statements of historical facts. Forward-looking statements may be identified by the use of words like “expect,” “estimate,” “will,” “may,” or expressions of similar meaning. Forward-looking statements reflect management’s evaluation of information currently available and are based on the Company’s current expectations and assumptions regarding the impact from the COVID-19 pandemic, the Company’s business, the economy and other future conditions. Specific factors that could cause future results to differ from those expressed by the forward-looking statements include, but are not limited to, risks related to the ongoing impact of the COVID-19 pandemic and those discussed in the Company’s Annual Report for the year ended December 31, 2019 filed with the Securities and Exchange Commission (“SEC”), in subsequent Quarterly Reports on Form 10-Q and in other filings and furnishings made by the Company with the SEC from time to time. Other unknown or unpredictable factors could also have material adverse effects on the Company’s performance. As a result of these or other factors, the Company’s actual results may differ materially from those contemplated by the forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof and are not a guarantee of future performance. The Company undertakes no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.